This Stock Is On the Upswing

The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor David Meier discuss topics across the investing world.

MAKO Surgical is an outstanding company that is in the early stages of its growth. Dave believes the company will be a long-term winner from here. In this video, John and Dave talk about the company's recent performance, and then consider its unique advantage vis-a-vis the competition.

Health-care investors are always looking for the next big breakthrough. Motley Fool Co-founder David Gardner recently identified MAKO Surgical as a company that he believes is poised for monster returns. To learn more about this top pick today, enjoy the special free report: "Discover the Next Rule-Breaking Multibagger." Don't miss out on this limited-time offer and your opportunity to discover this game-changing company before the market does. Click here to access your report -- it's totally free.

David Meier has no positions in the stocks mentioned above. John Reeves has no positions in the stocks mentioned above. The Motley Fool owns shares of MAKO Surgical. Motley Fool newsletter services recommend Intuitive Surgical, MAKO Surgical , Smith & Nephew, and Stryker. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (4) | Recommend This Article (15)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 09, 2012, at 10:58 AM, Borisbmx wrote:

    in the most recent quarter the sales advanced 122% to $32 million, and gross profits advanced 151% to $22 million

  • Report this Comment On March 09, 2012, at 12:21 PM, Bodagetta wrote:

    Sales great, profits great, more and more adopters. Seems quite a value priced equity at present. Hip & knee replacements are getting almost as common as root canals. The Makoplasty robotic system in minimally invasive, faster recovery, and bottom line for hospitals.....more volume!

    Mako will either be the one everyone will say, "Remember when MAKO was $38" (like AAPL) or get bought by competitor at a premium to stockholders. Either way I am long on this one.

  • Report this Comment On March 09, 2012, at 8:18 PM, jdwelch62 wrote:

    Agreed. I was able to only add a little bit of MAKO to my wife's portfolio at the beginning of the year, and I'd like to add more to mine, but I just don't have the dry powder at the moment. I believe this company is destined to shoot up (or get scooped up), but I (selfishly) hope the price stays relatively where it is for a little while so I can grab some more before that happens!

    :-)

  • Report this Comment On March 11, 2012, at 2:09 PM, dpgennrich wrote:

    This stock is going to rock! Are there another's anyone knows of in a similar embryonic stage with medical robotic solution(s)?

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1807026, ~/Articles/ArticleHandler.aspx, 10/23/2014 4:51:07 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement